Brief: Theratechnologies Enters Into Definitive Agreement To Be Acquired By Cb Biotechnology, An Affiliate Of Future Pak
03/07/2025 03:14
July 2 (Reuters) - Theratechnologies Inc TH.TO: THERATECHNOLOGIES ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY CB BIOTECHNOLOGY, AN AFFILIATE OF FUTURE PAK THERATECHNOLOGIES INC - TO BE BUYD BY CB BIOTECHNOLOGY FOR $3.01 PER SHARE THERATECHNOLOGIES INC - TOTAL DEAL CONSIDERATION UP TO $254 MILLION THERATECHNOLOGIES INC - TO BECOME PRIVATELY HELD COMPANY THERATECHNOLOGIES - PURCHASER WILL ALSO PAY ONE CVR PER SHARE FOR ADDITIONAL AGGREGATE CASH PAYMENTS OF UP TO US$1.19 PER CVR Source text: ID:nGNXLH2j6 Further company coverage: TH.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theratechnologies
See all newsBrief: Theratechnologies Receives Final Court Approval On To Be Acquired By Future Pak
Brief: Theratechnologies Inc - Iss And Glass Lewis Recommend Voting 'For' Future Pak Arrangement
Canadian drugmaker Theratechnologies beats Q2 revenue estimates on strong demand
Brief: Theratechnologies Enters Into Definitive Agreement To Be Acquired By Cb Biotechnology, An Affiliate Of Future Pak
Brief: Theratechnologies Inc Decided To Further Evaluate Potential Sale Of Company Through An Open And Non-Exclusive Process